Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD
Abstract Inhaled bronchodilators are central for the treatment of chronic obstructive pulmonary disease (COPD), as they can provide symptom relief and reduce the frequency and severity of exacerbations while improving health status and exercise tolerance. In 2017, glycopyrrolate (GLY) delivered via...
Saved in:
Main Authors: | Donald P. Tashkin, Xiaoli Niu, Sanjay Sharma, Shahin Sanjar |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/34def7afb7e54f30b071260caa02f52c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
by: Mònica Monteagudo, et al.
Published: (2021) -
Feasibility and applicability of the paper and electronic COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in primary care: a clinimetric study
by: J. W. H. Kocks, et al.
Published: (2017) -
Mepolizumab and COPD in Real Life
by: Fernando Revuelta-Salgado, et al.
Published: (2022) -
Correction to: Measuring disease activity in COPD: is clinically important deterioration the answer?
by: Dave Singh, et al.
Published: (2021) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
by: Jafar Aljazeeri, et al.
Published: (2021)